View Financial HealthAehr Test Systems 배당 및 자사주 매입배당 기준 점검 0/6Aehr Test Systems 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-0.6%자사주 매입 수익률총 주주 수익률-0.6%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates새 내러티브 • Apr 21AEHR Insiders Cashed Out $25.9M After Years of Shareholder DilutionHeavy insider selling, repeated dilution, and weakening fundamentals raise serious questions about shareholder alignment Aehr Test Systems (NASDAQ: AEHR) has often been presented as a high-growth semiconductor equipment story tied to silicon carbide, EV power devices, and emerging AI infrastructure demand. But behind the narrative lies a more uncomfortable reality for shareholders: years of dilution followed by a major insider cash-out during a sharp stock rally.Recent Insider Transactions • Apr 16Chief Operating Officer recently sold US$247k worth of stockOn the 9th of April, Adil Engineer sold around 4k shares on-market at roughly US$66.30 per share. This transaction amounted to 8.3% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$420k. This was Adil's only on-market trade for the last 12 months.Recent Insider Transactions Derivative • Apr 12President notifies of intention to sell stockGayn Erickson intends to sell 96k shares in the next 90 days after lodging an Intent To Sell Form on the 10th of April. If the sale is conducted around the recent share price of US$70.58, it would amount to US$6.8m. For the year to May 2019, Gayn's total compensation was 14% salary and 86% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since June 2025, Gayn's direct individual holding has increased from 374.92k shares to 418.78k. Company insiders have collectively sold US$1.3m more than they bought, via options and on-market transactions in the last 12 months.공지 • Apr 09Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $60 million.Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $60 million. Security Name: Common Stock Security Type: Common Stock Transaction Features: At the Market OfferingReported Earnings • Apr 08Third quarter 2026 earnings released: US$0.10 loss per share (vs US$0.022 loss in 3Q 2025)Third quarter 2026 results: US$0.10 loss per share (further deteriorated from US$0.022 loss in 3Q 2025). Revenue: US$10.3m (down 44% from 3Q 2025). Net loss: US$3.20m (loss widened 398% from 3Q 2025). Revenue is forecast to grow 40% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Semiconductor industry in the US. Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has increased by 31% per year, which means it is well ahead of earnings.Seeking Alpha • Apr 08Aehr Test Systems: The Quiet Bottleneck In AI InfrastructureSummary Revenue declined 44% year over year to $10.3 million, but bookings surged to $37.2 million, up 6× quarter over quarter. Book-to-bill exceeded 3.5×, with backlog at $38.7 million and effective backlog reaching $50.9 million after quarter-end. Only 5–20% of ASICs and ~50% of AI accelerators use burn-in, leaving significant adoption-driven growth ahead. Q4 bookings reached $12.2 million in just 5 weeks, already doubling the entire Q2 booking level of $6.2 million. Valuation stands at ~33× FY2026 P/S, but strong demand suggests FY2027 revenue estimates near $82 million may prove conservative. Read the full article on Seeking Alpha공지 • Mar 30Aehr Test Systems, Inc. to Report Q3, 2026 Results on Apr 07, 2026Aehr Test Systems, Inc. announced that they will report Q3, 2026 results After-Market on Apr 07, 2026Price Target Changed • Mar 05Price target increased by 49% to US$36.33Up from US$24.33, the current price target is an average from 3 analysts. New target price is 10% below last closing price of US$40.49. Stock is up 359% over the past year. The company posted a net loss per share of US$0.13 last year.New Risk • Mar 03New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (16% average weekly change). Minor Risk Significant insider selling over the past 3 months (US$646k sold).Recent Insider Transactions • Feb 16Founder & Independent Chairman recently sold US$420k worth of stockOn the 13th of February, Rhea Posedel sold around 14k shares on-market at roughly US$30.02 per share. This transaction amounted to 2.7% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Rhea's only on-market trade for the last 12 months.Recent Insider Transactions Derivative • Feb 15Founder & Independent Chairman notifies of intention to sell stockRhea Posedel intends to sell 14k shares in the next 90 days after lodging an Intent To Sell Form on the 13th of February. If the sale is conducted around the recent share price of US$27.89, it would amount to US$390k. Since September 2025, Rhea has owned 493.73k shares directly. Company insiders have collectively sold US$888k more than they bought, via options and on-market transactions in the last 12 months.Recent Insider Transactions • Jan 27Independent Director recently sold US$143k worth of stockOn the 22nd of January, Laura Oliphant sold around 5k shares on-market at roughly US$31.40 per share. This transaction amounted to 21% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$154k. Insiders have been net sellers, collectively disposing of US$715k more than they bought in the last 12 months.Recent Insider Transactions Derivative • Jan 22Independent Director notifies of intention to sell stockLaura Oliphant intends to sell 5k shares in the next 90 days after lodging an Intent To Sell Form on the 22nd of January. If the sale is conducted around the recent share price of US$31.40, it would amount to US$143k. Since September 2025, Laura has owned 16.20k shares directly. Company insiders have collectively sold US$662k more than they bought, via options and on-market transactions in the last 12 months.분석 기사 • Jan 17Aehr Test Systems, Inc.'s (NASDAQ:AEHR) 34% Price Boost Is Out Of Tune With RevenuesAehr Test Systems, Inc. ( NASDAQ:AEHR ) shareholders would be excited to see that the share price has had a great...Reported Earnings • Jan 09Second quarter 2026 earnings released: US$0.11 loss per share (vs US$0.035 loss in 2Q 2025)Second quarter 2026 results: US$0.11 loss per share (further deteriorated from US$0.035 loss in 2Q 2025). Revenue: US$9.88m (down 27% from 2Q 2025). Net loss: US$3.23m (loss widened 214% from 2Q 2025). Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Semiconductor industry in the US. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.공지 • Jan 09Aehr Test Systems, Inc. Reinstates Earnings Guidance for the Second Half of Fiscal 2026Aehr Test Systems, Inc. reinstated earnings guidance for the second half of fiscal 2026. For the period, which began November 29, 2025 and ends this May 29, 2026, Aehr expects revenue between $25 million and $30 million.공지 • Dec 30Aehr Test Systems, Inc. to Report Q2, 2026 Results on Jan 08, 2026Aehr Test Systems, Inc. announced that they will report Q2, 2026 results After-Market on Jan 08, 2026Buy Or Sell Opportunity • Nov 21Now 25% overvalued after recent price riseOver the last 90 days, the stock has risen 12% to US$20.27. The fair value is estimated to be US$16.26, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 3.5% over the last 3 years. Meanwhile, the company became loss making.분석 기사 • Nov 20Aehr Test Systems, Inc. (NASDAQ:AEHR) Shares May Have Slumped 31% But Getting In Cheap Is Still UnlikelyAehr Test Systems, Inc. ( NASDAQ:AEHR ) shares have retraced a considerable 31% in the last month, reversing a fair...Recent Insider Transactions • Nov 07Independent Director recently sold US$154k worth of stockOn the 5th of November, Howard Slayen sold around 6k shares on-market at roughly US$25.73 per share. This transaction amounted to 2.9% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$223k. Insiders have been net sellers, collectively disposing of US$573k more than they bought in the last 12 months.Recent Insider Transactions Derivative • Oct 24Insider exercised options to buy US$2.8m worth of stock.On the 22nd of October, Vernon Rogers exercised options to buy 110k shares at a strike price of around US$2.03, costing a total of US$224k. This transaction amounted to 297% of their direct individual holding at the time of the trade. Since December 2024, Vernon's direct individual holding has increased from 19.35k shares to 147.62k. Company insiders have collectively sold US$508k more than they bought, via options and on-market transactions in the last 12 months.Recent Insider Transactions • Oct 13Independent Director recently sold US$223k worth of stockOn the 9th of October, Fariba Danesh sold around 9k shares on-market at roughly US$24.79 per share. This transaction amounted to 73% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$418k more than they bought in the last 12 months.Reported Earnings • Oct 07First quarter 2026 earnings released: US$0.07 loss per share (vs US$0.023 profit in 1Q 2025)First quarter 2026 results: US$0.07 loss per share (down from US$0.023 profit in 1Q 2025). Revenue: US$11.0m (down 16% from 1Q 2025). Net loss: US$2.08m (down 416% from profit in 1Q 2025). Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Semiconductor industry in the US. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.공지 • Sep 29Aehr Test Systems, Inc. to Report Q1, 2026 Results on Oct 06, 2025Aehr Test Systems, Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on Oct 06, 2025공지 • Sep 11Aehr Test Systems, Inc., Annual General Meeting, Oct 20, 2025Aehr Test Systems, Inc., Annual General Meeting, Oct 20, 2025. Location: 400kato terrace, california 94539, fremont United StatesNew Risk • Aug 29New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (17% average weekly change). Minor Risk Significant insider selling over the past 3 months (US$150k sold).분석 기사 • Aug 28There's Reason For Concern Over Aehr Test Systems, Inc.'s (NASDAQ:AEHR) Massive 29% Price JumpDespite an already strong run, Aehr Test Systems, Inc. ( NASDAQ:AEHR ) shares have been powering on, with a gain of 29...Buy Or Sell Opportunity • Aug 25Now 44% overvalued after recent price riseOver the last 90 days, the stock has risen 148% to US$24.59. The fair value is estimated to be US$17.08, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making.분석 기사 • Aug 20Calculating The Intrinsic Value Of Aehr Test Systems, Inc. (NASDAQ:AEHR)NasdaqCM:AEHR 1 Year Share Price vs Fair Value Explore Aehr Test Systems's Fair Values from the Community and select...Recent Insider Transactions • Jul 30Independent Director recently sold US$108k worth of stockOn the 25th of July, Laura Oliphant sold around 5k shares on-market at roughly US$21.50 per share. This transaction amounted to 24% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought US$115k more than they sold in the last 12 months.Recent Insider Transactions Derivative • Jul 23Founder & Independent Chairman notifies of intention to sell stockRhea Posedel intends to sell 18k shares in the next 90 days after lodging an Intent To Sell Form on the 22nd of July. If the sale is conducted around the recent share price of US$19.83, it would amount to US$357k. Since September 2024, Rhea's direct individual holding has increased from 496.46k shares to 523.67k. Company insiders have collectively bought US$68k more than they sold, via options and on-market transactions, in the last 12 months.New Risk • Jul 21New minor risk - Insider sellingThere has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: US$88k This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Significant insider selling over the past 3 months (US$88k sold).Buy Or Sell Opportunity • Jul 09Now 30% undervaluedOver the last 90 days, the stock has risen 63% to US$13.29. The fair value is estimated to be US$18.95, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making.분석 기사 • Jul 09Further Upside For Aehr Test Systems, Inc. (NASDAQ:AEHR) Shares Could Introduce Price Risks After 34% BounceAehr Test Systems, Inc. ( NASDAQ:AEHR ) shares have continued their recent momentum with a 34% gain in the last month...Board Change • Jul 08Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Independent Director Fariba Danesh was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공지 • Jun 30Aehr Test Systems, Inc. to Report Q4, 2025 Results on Jul 08, 2025Aehr Test Systems, Inc. announced that they will report Q4, 2025 results After-Market on Jul 08, 2025새 내러티브 • Jun 27Aehr Test Systems will leverage AI for significant growth potentialThere are a couple of reasons that I like this stock, but I still need to look more into it, however I do currently own some shares. As of right now AEHR is in a good position with AI about to explodeReported Earnings • Apr 09Third quarter 2025 earnings released: US$0.022 loss per share (vs US$0.051 loss in 3Q 2024)Third quarter 2025 results: US$0.022 loss per share (improved from US$0.051 loss in 3Q 2024). Revenue: US$18.3m (up 142% from 3Q 2024). Net loss: US$643.0k (loss narrowed 56% from 3Q 2024). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Semiconductor industry in the US. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Apr 03Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to US$6.85, the stock trades at a trailing P/E ratio of 9.2x. Average forward P/E is 20x in the Semiconductor industry in the US. Total loss to shareholders of 28% over the past three years.공지 • Mar 28Aehr Test Systems, Inc. to Report Q3, 2025 Results on Apr 08, 2025Aehr Test Systems, Inc. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Apr 08, 2025Seeking Alpha • Mar 27Aehr Test Systems: An Earnings Show-Me Story, Optimistic For A TurnaroundSummary Aehr Test Systems has faced significant challenges, including weak silicon carbide sales and intense competition, but remains a buy due to low valuation and potential EPS growth. Despite a sharp underperformance since early 2024 and a disappointing Q2, AEHR is diversifying revenue streams and expanding into AI processors, which could drive future growth. Key risks include ongoing supply chain issues, competition, and uncertainties in the silicon carbide market, but recent positive economic data from China offers hope for a turnaround. Technically, AEHR faces resistance at $10 and bearish indicators, but a bullish response to earnings could target a long-term upside gap around $16. Read the full article on Seeking AlphaValuation Update With 7 Day Price Move • Mar 17Investor sentiment improves as stock rises 20%After last week's 20% share price gain to US$9.77, the stock trades at a trailing P/E ratio of 13.2x. Average forward P/E is 21x in the Semiconductor industry in the US. Total loss to shareholders of 4.4% over the past three years.Valuation Update With 7 Day Price Move • Feb 19Investor sentiment improves as stock rises 22%After last week's 22% share price gain to US$12.47, the stock trades at a trailing P/E ratio of 16.8x. Average forward P/E is 24x in the Semiconductor industry in the US. Total returns to shareholders of 6.3% over the past three years.분석 기사 • Feb 06Not Many Are Piling Into Aehr Test Systems, Inc. (NASDAQ:AEHR) Stock Yet As It Plummets 34%Aehr Test Systems, Inc. ( NASDAQ:AEHR ) shareholders won't be pleased to see that the share price has had a very rough...Valuation Update With 7 Day Price Move • Jan 20Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to US$12.46, the stock trades at a trailing P/E ratio of 16.8x. Average forward P/E is 21x in the Semiconductor industry in the US. Total returns to shareholders of 5.3% over the past three years.Price Target Changed • Jan 17Price target decreased by 24% to US$19.00Down from US$25.00, the current price target is provided by 1 analyst. New target price is 52% above last closing price of US$12.46. Stock is down 25% over the past year. The company posted earnings per share of US$1.15 last year.Seeking Alpha • Jan 16Aehr Test Systems: Selloff Was Justified But I'm Still Cautiously Optimistic (Rating Downgrade)Summary Aehr Test Systems' competitive advantage lies in its best-in-class test systems used for both EV and AI chips. The company's poor 2024 performance was due to an EV slowdown and reduced capex from its largest customer. Recent orders from AI and GaN customers signal strong growth for the second half of 2025 and increasing trust in Aehr's technology. Read the full article on Seeking AlphaReported Earnings • Jan 14Second quarter 2025 earnings released: US$0.035 loss per share (vs US$0.21 profit in 2Q 2024)Second quarter 2025 results: US$0.035 loss per share (down from US$0.21 profit in 2Q 2024). Revenue: US$13.5m (down 37% from 2Q 2024). Net loss: US$1.03m (down 117% from profit in 2Q 2024). Revenue is forecast to grow 34% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Semiconductor industry in the US. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.공지 • Jan 14Aehr Test Systems Reiterates Earnings Guidance for Fiscal Year Ending May 30, 2025For the fiscal year ending May 30, 2025, Aehr Test Systems, Inc. reiterated its previously provided guidance for total revenue of at least $70 million.공지 • Jan 01Aehr Test Systems, Inc. to Report Q2, 2025 Results on Jan 13, 2025Aehr Test Systems, Inc. announced that they will report Q2, 2025 results at 4:00 PM, US Eastern Standard Time on Jan 13, 2025Valuation Update With 7 Day Price Move • Dec 30Investor sentiment improves as stock rises 21%After last week's 21% share price gain to US$16.98, the stock trades at a trailing P/E ratio of 17.3x. Average forward P/E is 20x in the Semiconductor industry in the US. Total loss to shareholders of 27% over the past three years.Seeking Alpha • Dec 17Aehr Test Systems: With A Turnaround In Sight, It's High On My Watchlist To Build A Proper PositionSummary Aehr Test Systems' share price dropped 30% since the last update but shows potential recovery, driven by positive news on diversification and SiC segment outlook. Latest earnings beat expectations with $13M in revenue, mainly from SiC; diversification into GaN and AI segments is progressing. Secured initial AI orders, boosting stock by 21%; diversification could bring significant revenue growth, but competition may arise. Despite positive signs, I remain cautious due to SiC market recovery uncertainty and macroeconomic factors, holding off on a buy rating for now. Read the full article on Seeking Alpha분석 기사 • Dec 17Improved Earnings Required Before Aehr Test Systems, Inc. (NASDAQ:AEHR) Stock's 34% Jump Looks JustifiedAehr Test Systems, Inc. ( NASDAQ:AEHR ) shares have had a really impressive month, gaining 34% after a shaky period...Valuation Update With 7 Day Price Move • Dec 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to US$14.49, the stock trades at a trailing P/E ratio of 14.7x. Average forward P/E is 20x in the Semiconductor industry in the US. Total loss to shareholders of 5.8% over the past three years.공지 • Dec 06Gewirtz & Grossman LLC Notifies Class Action Lawsuit Filed Against Aehr Test Systems, IncGewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Aehr Test Systems, Inc. and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Aehr securities between January 9, 2024 and March 24, 2024, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site. The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) contrary to prior representations to investors, Aehr was continuing to experience substantial delays in customer orders; (2) the foregoing issue was likely to have a material negative impact on the Company's revenue growth; (3) accordingly, the Company's business and/or financial prospects were overstated; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/AEHR. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. If you suffered a loss in Aehr you have until February 3, 2025, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful. Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.Valuation Update With 7 Day Price Move • Nov 01Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to US$14.08, the stock trades at a trailing P/E ratio of 14.3x. Average forward P/E is 21x in the Semiconductor industry in the US. Total loss to shareholders of 45% over the past three years.분석 기사 • Oct 23Aehr Test Systems' (NASDAQ:AEHR) Earnings Might Not Be As Promising As They SeemAehr Test Systems, Inc.'s ( NASDAQ:AEHR ) stock performed strongly after the recent earnings report. Investors should...분석 기사 • Oct 19Aehr Test Systems, Inc.'s (NASDAQ:AEHR) Shares Bounce 30% But Its Business Still Trails The MarketAehr Test Systems, Inc. ( NASDAQ:AEHR ) shareholders are no doubt pleased to see that the share price has bounced 30...공지 • Oct 16Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $40 million.Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $40 million. Security Name: Common Stock Security Type: Common Stock Transaction Features: At the Market OfferingReported Earnings • Oct 11First quarter 2025 earnings released: EPS: US$0.023 (vs US$0.16 in 1Q 2024)First quarter 2025 results: EPS: US$0.023 (down from US$0.16 in 1Q 2024). Revenue: US$13.1m (down 36% from 1Q 2024). Net income: US$660.0k (down 86% from 1Q 2024). Profit margin: 5.0% (down from 23% in 1Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Semiconductor industry in the US. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.공지 • Oct 11Aehr Test Systems, Inc. Reaffirms Earnings Guidance for the Fiscal Year Ending May 30, 2025Aehr Test Systems, Inc. reaffirms earnings guidance for the fiscal year ending May 30, 2025. For the fiscal year ending May 30, 2025, Aehr is reiterating its previously provided guidance for total revenue of at least $70 million and net profit before taxes of at least 10% of revenue.Seeking Alpha • Oct 11Aehr Test Systems: Enthusiastic Management But Weak Near-Term Prospects, HoldSummary Shares of wafer level test and burn-in system supplier Aehr Test Systems rallied after the close of Thursday's regular session as investors cheered better-than-expected Q1/FY2025 results. Results and backlog benefited from the recent acquisition of Incal Technologies. As usual, management remained enthusiastic about the company's diversification into new markets, including AI. However, expansion into new markets won't offset persistent weakness in the core silicon carbide system business anytime soon. While market participants are likely to celebrate perceived AI market prospects in the near-term, persistent weakness in the company's core business is keeping me sidelined for now. Read the full article on Seeking Alpha공지 • Oct 02Aehr Test Systems, Inc. to Report Q1, 2025 Results on Oct 10, 2024Aehr Test Systems, Inc. announced that they will report Q1, 2025 results After-Market on Oct 10, 2024공지 • Sep 12Aehr Test Systems, Inc., Annual General Meeting, Oct 21, 2024Aehr Test Systems, Inc., Annual General Meeting, Oct 21, 2024. Location: 400 kato terrace, california 94539, fremont United States분석 기사 • Sep 07Aehr Test Systems (NASDAQ:AEHR) Is Experiencing Growth In Returns On CapitalTo find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...Valuation Update With 7 Day Price Move • Aug 06Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to US$15.01, the stock trades at a trailing P/E ratio of 13.4x. Average forward P/E is 18x in the Semiconductor industry in the US. Total returns to shareholders of 131% over the past three years.Recent Insider Transactions • Aug 01Independent Director recently sold US$186k worth of stockOn the 30th of July, Fariba Danesh sold around 10k shares on-market at roughly US$18.59 per share. This transaction amounted to 70% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$967k more than they bought in the last 12 months.Price Target Changed • Jul 18Price target increased by 108% to US$25.00Up from US$12.00, the current price target is provided by 1 analyst. New target price is 33% above last closing price of US$18.83. Stock is down 61% over the past year. The company posted earnings per share of US$1.15 last year.Reported Earnings • Jul 17Full year 2024 earnings released: EPS: US$1.15 (vs US$0.52 in FY 2023)Full year 2024 results: EPS: US$1.15 (up from US$0.52 in FY 2023). Revenue: US$66.2m (up 1.9% from FY 2023). Net income: US$33.2m (up 128% from FY 2023). Profit margin: 50% (up from 22% in FY 2023). The increase in margin was primarily driven by lower expenses. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Semiconductor industry in the US. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.공지 • Jul 17Aehr Test Systems (NasdaqCM:AEHR) agreed to acquire Incal Technology, Inc for $23.1.Aehr Test Systems (NasdaqCM:AEHR) agreed to acquire Incal Technology, Inc for $23.1 on July 15, 2024. A cash consideration of $14 million will be paid by Aehr Test Systems. The consideration consists of 0.55 million common equity of Aehr Test Systems to be issued for common equity of Incal Technology, Inc. The transaction has been approved by the board of directors of both companies and the Acquisition is expected to close within 60 days, subject to customary closing conditions. The transaction is subject to certain post-closing adjustments with respect to working capital. Latham & Watkins LLP acted as legal advisor for Aehr Test Systems.분석 기사 • Jul 17Aehr Test Systems' (NASDAQ:AEHR) 27% Share Price Surge Not Quite Adding UpDespite an already strong run, Aehr Test Systems ( NASDAQ:AEHR ) shares have been powering on, with a gain of 27% in...공지 • Jul 17Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 30, 2025Aehr Test Systems provided earnings guidance for the fiscal year ending May 30, 2025. For the period, the company expects total revenue of at least $70 million and net profit before taxes of at least 10% of revenue.Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improves as stock rises 40%After last week's 40% share price gain to US$15.75, the stock trades at a trailing P/E ratio of 29.6x. Average forward P/E is 23x in the Semiconductor industry in the US. Total returns to shareholders of 363% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$9.07 per share.공지 • Jul 04Aehr Test Systems to Report Q4, 2024 Results on Jul 16, 2024Aehr Test Systems announced that they will report Q4, 2024 results After-Market on Jul 16, 2024Buy Or Sell Opportunity • Jul 01Now 23% overvaluedOver the last 90 days, the stock has fallen 6.6% to US$11.10. The fair value is estimated to be US$8.99, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year.Valuation Update With 7 Day Price Move • Jun 27Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to US$10.17, the stock trades at a trailing P/E ratio of 19.1x. Average forward P/E is 23x in the Semiconductor industry in the US. Total returns to shareholders of 268% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$8.97 per share.Buy Or Sell Opportunity • Jun 22Now 20% overvaluedOver the last 90 days, the stock has fallen 26% to US$10.80. The fair value is estimated to be US$8.97, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year.New Risk • Jun 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings are forecast to decline by an average of 14% per year for the foreseeable future. High level of non-cash earnings (34% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Shareholders have been diluted in the past year (2.0% increase in shares outstanding).Seeking Alpha • Jun 07Aehr Test Systems: The Bottom Might Be InSummary Aehr Test Systems may be at the bottom of its business cycle, and long-term growth potential remains. The company's financials have been impacted by slower demand and falling revenues, but stronger bookings and backlog are encouraging signs of a reversal of the slowdown. The market growth potential for AEHR is strong, the EV market should drive growth for years to come. Read the full article on Seeking Alpha분석 기사 • Jun 06We Like These Underlying Return On Capital Trends At Aehr Test Systems (NASDAQ:AEHR)Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...Valuation Update With 7 Day Price Move • Jun 05Investor sentiment improves as stock rises 15%After last week's 15% share price gain to US$12.75, the stock trades at a trailing P/E ratio of 23.9x. Average forward P/E is 21x in the Semiconductor industry in the US. Total returns to shareholders of 381% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$8.78 per share.Board Change • Jun 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Independent Director Fariba Danesh was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.분석 기사 • May 01Why Aehr Test Systems (NASDAQ:AEHR) Could Be Worth WatchingAehr Test Systems ( NASDAQ:AEHR ), is not the largest company out there, but it saw a double-digit share price rise of...Buy Or Sell Opportunity • Apr 24Now 24% overvaluedOver the last 90 days, the stock has fallen 32% to US$11.14. The fair value is estimated to be US$8.96, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year.분석 기사 • Apr 18Aehr Test Systems' (NASDAQ:AEHR) Solid Earnings May Rest On Weak FoundationsAehr Test Systems' ( NASDAQ:AEHR ) robust recent earnings didn't do much to move the stock. However the statutory...New Risk • Apr 12New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 14% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings are forecast to decline by an average of 14% per year for the foreseeable future. High level of non-cash earnings (34% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Shareholders have been diluted in the past year (4.2% increase in shares outstanding). Significant insider selling over the past 3 months (US$152k sold).Reported Earnings • Apr 10Third quarter 2024 earnings released: US$0.051 loss per share (vs US$0.15 profit in 3Q 2023)Third quarter 2024 results: US$0.051 loss per share (down from US$0.15 profit in 3Q 2023). Revenue: US$7.56m (down 56% from 3Q 2023). Net loss: US$1.47m (down 136% from profit in 3Q 2023). Revenue is expected to decline by 5.7% p.a. on average during the next 2 years, while revenues in the Semiconductor industry in the US are expected to grow by 16%. Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 72% per year, which means it is significantly lagging earnings growth.공지 • Apr 10Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024Aehr Test Systems provides earnings guidance for the fiscal year ending May 31, 2024. For the period, the company reiterating its previously provided guidance for total revenue of greater than $65 million and GAAP net income of approximately $11 million or more, or $0.38 per diluted share.분석 기사 • Apr 01Some Confidence Is Lacking In Aehr Test Systems (NASDAQ:AEHR) As Shares Slide 30%Unfortunately for some shareholders, the Aehr Test Systems ( NASDAQ:AEHR ) share price has dived 30% in the last thirty...Valuation Update With 7 Day Price Move • Mar 29Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to US$12.40, the stock trades at a trailing P/E ratio of 17x. Average forward P/E is 21x in the Semiconductor industry in the US. Total returns to shareholders of 382% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$7.15 per share.공지 • Mar 26Aehr Test Systems to Report Q3, 2024 Results on Apr 09, 2024Aehr Test Systems announced that they will report Q3, 2024 results on Apr 09, 2024Valuation Update With 7 Day Price Move • Mar 15Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to US$14.50, the stock trades at a trailing P/E ratio of 19.9x. Average forward P/E is 21x in the Semiconductor industry in the US. Total returns to shareholders of 464% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$7.14 per share.분석 기사 • Feb 21Investors Shouldn't Overlook Aehr Test Systems' (NASDAQ:AEHR) Impressive Returns On CapitalThere are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...Seeking Alpha • Feb 14Aehr Test Systems Faces Cyclical Headwinds (Rating Downgrade)Summary Aehr Test Systems has experienced cyclical headwinds that have affected its near-term prospects. Despite these challenges, the company's proprietary wafer-level test systems continue to benefit from rising demand for chips that require thorough testing. AEHR's XP systems, which can test multiple wafers at once, offer cost and space savings, and the company has additional growth opportunities in segments such as SiC, GaN, and SiPh. The cyclical headwinds will pass but could very well last a little longer. Read the full article on Seeking AlphaValuation Update With 7 Day Price Move • Feb 12Investor sentiment improves as stock rises 17%After last week's 17% share price gain to US$17.21, the stock trades at a trailing P/E ratio of 23.6x. Average forward P/E is 19x in the Semiconductor industry in the US. Total returns to shareholders of 450% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$7.30 per share.Recent Insider Transactions Derivative • Feb 10Founder & Independent Chairman exercised options to buy US$310k worth of stock.On the 6th of February, Rhea Posedel exercised options to buy 18k shares at a strike price of around US$3.93, costing a total of US$71k. This transaction amounted to 3.8% of their direct individual holding at the time of the trade. Since June 2023, Rhea's direct individual holding has decreased from 571.22k shares to 477.11k. Company insiders have collectively sold US$21m more than they bought, via options and on-market transactions in the last 12 months.분석 기사 • Feb 01Should You Investigate Aehr Test Systems (NASDAQ:AEHR) At US$14.85?Aehr Test Systems ( NASDAQ:AEHR ), is not the largest company out there, but it received a lot of attention from a...New Risk • Jan 22New minor risk - Insider sellingThere has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: US$160k This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (52% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Shareholders have been diluted in the past year (3.9% increase in shares outstanding). Significant insider selling over the past 3 months (US$160k sold).지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 AEHR 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: AEHR 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Aehr Test Systems 배당 수익률 vs 시장AEHR의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (AEHR)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.2%업계 평균 (Semiconductor)0.3%분석가 예측 (AEHR) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 AEHR 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 AEHR 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 AEHR 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: AEHR 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/07 15:38종가2026/05/07 00:00수익2026/02/27연간 수익2025/05/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Aehr Test Systems, Inc.는 5명의 분석가가 다루고 있습니다. 이 중 4명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Christian SchwabCraig-Hallum Capital Group LLCEgor TolmachevFreedom BrokerDanial YermakhanFreedom Broker2명의 분석가 더 보기
새 내러티브 • Apr 21AEHR Insiders Cashed Out $25.9M After Years of Shareholder DilutionHeavy insider selling, repeated dilution, and weakening fundamentals raise serious questions about shareholder alignment Aehr Test Systems (NASDAQ: AEHR) has often been presented as a high-growth semiconductor equipment story tied to silicon carbide, EV power devices, and emerging AI infrastructure demand. But behind the narrative lies a more uncomfortable reality for shareholders: years of dilution followed by a major insider cash-out during a sharp stock rally.
Recent Insider Transactions • Apr 16Chief Operating Officer recently sold US$247k worth of stockOn the 9th of April, Adil Engineer sold around 4k shares on-market at roughly US$66.30 per share. This transaction amounted to 8.3% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$420k. This was Adil's only on-market trade for the last 12 months.
Recent Insider Transactions Derivative • Apr 12President notifies of intention to sell stockGayn Erickson intends to sell 96k shares in the next 90 days after lodging an Intent To Sell Form on the 10th of April. If the sale is conducted around the recent share price of US$70.58, it would amount to US$6.8m. For the year to May 2019, Gayn's total compensation was 14% salary and 86% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since June 2025, Gayn's direct individual holding has increased from 374.92k shares to 418.78k. Company insiders have collectively sold US$1.3m more than they bought, via options and on-market transactions in the last 12 months.
공지 • Apr 09Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $60 million.Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $60 million. Security Name: Common Stock Security Type: Common Stock Transaction Features: At the Market Offering
Reported Earnings • Apr 08Third quarter 2026 earnings released: US$0.10 loss per share (vs US$0.022 loss in 3Q 2025)Third quarter 2026 results: US$0.10 loss per share (further deteriorated from US$0.022 loss in 3Q 2025). Revenue: US$10.3m (down 44% from 3Q 2025). Net loss: US$3.20m (loss widened 398% from 3Q 2025). Revenue is forecast to grow 40% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Semiconductor industry in the US. Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has increased by 31% per year, which means it is well ahead of earnings.
Seeking Alpha • Apr 08Aehr Test Systems: The Quiet Bottleneck In AI InfrastructureSummary Revenue declined 44% year over year to $10.3 million, but bookings surged to $37.2 million, up 6× quarter over quarter. Book-to-bill exceeded 3.5×, with backlog at $38.7 million and effective backlog reaching $50.9 million after quarter-end. Only 5–20% of ASICs and ~50% of AI accelerators use burn-in, leaving significant adoption-driven growth ahead. Q4 bookings reached $12.2 million in just 5 weeks, already doubling the entire Q2 booking level of $6.2 million. Valuation stands at ~33× FY2026 P/S, but strong demand suggests FY2027 revenue estimates near $82 million may prove conservative. Read the full article on Seeking Alpha
공지 • Mar 30Aehr Test Systems, Inc. to Report Q3, 2026 Results on Apr 07, 2026Aehr Test Systems, Inc. announced that they will report Q3, 2026 results After-Market on Apr 07, 2026
Price Target Changed • Mar 05Price target increased by 49% to US$36.33Up from US$24.33, the current price target is an average from 3 analysts. New target price is 10% below last closing price of US$40.49. Stock is up 359% over the past year. The company posted a net loss per share of US$0.13 last year.
New Risk • Mar 03New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (16% average weekly change). Minor Risk Significant insider selling over the past 3 months (US$646k sold).
Recent Insider Transactions • Feb 16Founder & Independent Chairman recently sold US$420k worth of stockOn the 13th of February, Rhea Posedel sold around 14k shares on-market at roughly US$30.02 per share. This transaction amounted to 2.7% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Rhea's only on-market trade for the last 12 months.
Recent Insider Transactions Derivative • Feb 15Founder & Independent Chairman notifies of intention to sell stockRhea Posedel intends to sell 14k shares in the next 90 days after lodging an Intent To Sell Form on the 13th of February. If the sale is conducted around the recent share price of US$27.89, it would amount to US$390k. Since September 2025, Rhea has owned 493.73k shares directly. Company insiders have collectively sold US$888k more than they bought, via options and on-market transactions in the last 12 months.
Recent Insider Transactions • Jan 27Independent Director recently sold US$143k worth of stockOn the 22nd of January, Laura Oliphant sold around 5k shares on-market at roughly US$31.40 per share. This transaction amounted to 21% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$154k. Insiders have been net sellers, collectively disposing of US$715k more than they bought in the last 12 months.
Recent Insider Transactions Derivative • Jan 22Independent Director notifies of intention to sell stockLaura Oliphant intends to sell 5k shares in the next 90 days after lodging an Intent To Sell Form on the 22nd of January. If the sale is conducted around the recent share price of US$31.40, it would amount to US$143k. Since September 2025, Laura has owned 16.20k shares directly. Company insiders have collectively sold US$662k more than they bought, via options and on-market transactions in the last 12 months.
분석 기사 • Jan 17Aehr Test Systems, Inc.'s (NASDAQ:AEHR) 34% Price Boost Is Out Of Tune With RevenuesAehr Test Systems, Inc. ( NASDAQ:AEHR ) shareholders would be excited to see that the share price has had a great...
Reported Earnings • Jan 09Second quarter 2026 earnings released: US$0.11 loss per share (vs US$0.035 loss in 2Q 2025)Second quarter 2026 results: US$0.11 loss per share (further deteriorated from US$0.035 loss in 2Q 2025). Revenue: US$9.88m (down 27% from 2Q 2025). Net loss: US$3.23m (loss widened 214% from 2Q 2025). Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Semiconductor industry in the US. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
공지 • Jan 09Aehr Test Systems, Inc. Reinstates Earnings Guidance for the Second Half of Fiscal 2026Aehr Test Systems, Inc. reinstated earnings guidance for the second half of fiscal 2026. For the period, which began November 29, 2025 and ends this May 29, 2026, Aehr expects revenue between $25 million and $30 million.
공지 • Dec 30Aehr Test Systems, Inc. to Report Q2, 2026 Results on Jan 08, 2026Aehr Test Systems, Inc. announced that they will report Q2, 2026 results After-Market on Jan 08, 2026
Buy Or Sell Opportunity • Nov 21Now 25% overvalued after recent price riseOver the last 90 days, the stock has risen 12% to US$20.27. The fair value is estimated to be US$16.26, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 3.5% over the last 3 years. Meanwhile, the company became loss making.
분석 기사 • Nov 20Aehr Test Systems, Inc. (NASDAQ:AEHR) Shares May Have Slumped 31% But Getting In Cheap Is Still UnlikelyAehr Test Systems, Inc. ( NASDAQ:AEHR ) shares have retraced a considerable 31% in the last month, reversing a fair...
Recent Insider Transactions • Nov 07Independent Director recently sold US$154k worth of stockOn the 5th of November, Howard Slayen sold around 6k shares on-market at roughly US$25.73 per share. This transaction amounted to 2.9% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$223k. Insiders have been net sellers, collectively disposing of US$573k more than they bought in the last 12 months.
Recent Insider Transactions Derivative • Oct 24Insider exercised options to buy US$2.8m worth of stock.On the 22nd of October, Vernon Rogers exercised options to buy 110k shares at a strike price of around US$2.03, costing a total of US$224k. This transaction amounted to 297% of their direct individual holding at the time of the trade. Since December 2024, Vernon's direct individual holding has increased from 19.35k shares to 147.62k. Company insiders have collectively sold US$508k more than they bought, via options and on-market transactions in the last 12 months.
Recent Insider Transactions • Oct 13Independent Director recently sold US$223k worth of stockOn the 9th of October, Fariba Danesh sold around 9k shares on-market at roughly US$24.79 per share. This transaction amounted to 73% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$418k more than they bought in the last 12 months.
Reported Earnings • Oct 07First quarter 2026 earnings released: US$0.07 loss per share (vs US$0.023 profit in 1Q 2025)First quarter 2026 results: US$0.07 loss per share (down from US$0.023 profit in 1Q 2025). Revenue: US$11.0m (down 16% from 1Q 2025). Net loss: US$2.08m (down 416% from profit in 1Q 2025). Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Semiconductor industry in the US. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.
공지 • Sep 29Aehr Test Systems, Inc. to Report Q1, 2026 Results on Oct 06, 2025Aehr Test Systems, Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on Oct 06, 2025
공지 • Sep 11Aehr Test Systems, Inc., Annual General Meeting, Oct 20, 2025Aehr Test Systems, Inc., Annual General Meeting, Oct 20, 2025. Location: 400kato terrace, california 94539, fremont United States
New Risk • Aug 29New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (17% average weekly change). Minor Risk Significant insider selling over the past 3 months (US$150k sold).
분석 기사 • Aug 28There's Reason For Concern Over Aehr Test Systems, Inc.'s (NASDAQ:AEHR) Massive 29% Price JumpDespite an already strong run, Aehr Test Systems, Inc. ( NASDAQ:AEHR ) shares have been powering on, with a gain of 29...
Buy Or Sell Opportunity • Aug 25Now 44% overvalued after recent price riseOver the last 90 days, the stock has risen 148% to US$24.59. The fair value is estimated to be US$17.08, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making.
분석 기사 • Aug 20Calculating The Intrinsic Value Of Aehr Test Systems, Inc. (NASDAQ:AEHR)NasdaqCM:AEHR 1 Year Share Price vs Fair Value Explore Aehr Test Systems's Fair Values from the Community and select...
Recent Insider Transactions • Jul 30Independent Director recently sold US$108k worth of stockOn the 25th of July, Laura Oliphant sold around 5k shares on-market at roughly US$21.50 per share. This transaction amounted to 24% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought US$115k more than they sold in the last 12 months.
Recent Insider Transactions Derivative • Jul 23Founder & Independent Chairman notifies of intention to sell stockRhea Posedel intends to sell 18k shares in the next 90 days after lodging an Intent To Sell Form on the 22nd of July. If the sale is conducted around the recent share price of US$19.83, it would amount to US$357k. Since September 2024, Rhea's direct individual holding has increased from 496.46k shares to 523.67k. Company insiders have collectively bought US$68k more than they sold, via options and on-market transactions, in the last 12 months.
New Risk • Jul 21New minor risk - Insider sellingThere has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: US$88k This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Significant insider selling over the past 3 months (US$88k sold).
Buy Or Sell Opportunity • Jul 09Now 30% undervaluedOver the last 90 days, the stock has risen 63% to US$13.29. The fair value is estimated to be US$18.95, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making.
분석 기사 • Jul 09Further Upside For Aehr Test Systems, Inc. (NASDAQ:AEHR) Shares Could Introduce Price Risks After 34% BounceAehr Test Systems, Inc. ( NASDAQ:AEHR ) shares have continued their recent momentum with a 34% gain in the last month...
Board Change • Jul 08Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Independent Director Fariba Danesh was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공지 • Jun 30Aehr Test Systems, Inc. to Report Q4, 2025 Results on Jul 08, 2025Aehr Test Systems, Inc. announced that they will report Q4, 2025 results After-Market on Jul 08, 2025
새 내러티브 • Jun 27Aehr Test Systems will leverage AI for significant growth potentialThere are a couple of reasons that I like this stock, but I still need to look more into it, however I do currently own some shares. As of right now AEHR is in a good position with AI about to explode
Reported Earnings • Apr 09Third quarter 2025 earnings released: US$0.022 loss per share (vs US$0.051 loss in 3Q 2024)Third quarter 2025 results: US$0.022 loss per share (improved from US$0.051 loss in 3Q 2024). Revenue: US$18.3m (up 142% from 3Q 2024). Net loss: US$643.0k (loss narrowed 56% from 3Q 2024). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Semiconductor industry in the US. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Apr 03Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to US$6.85, the stock trades at a trailing P/E ratio of 9.2x. Average forward P/E is 20x in the Semiconductor industry in the US. Total loss to shareholders of 28% over the past three years.
공지 • Mar 28Aehr Test Systems, Inc. to Report Q3, 2025 Results on Apr 08, 2025Aehr Test Systems, Inc. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Apr 08, 2025
Seeking Alpha • Mar 27Aehr Test Systems: An Earnings Show-Me Story, Optimistic For A TurnaroundSummary Aehr Test Systems has faced significant challenges, including weak silicon carbide sales and intense competition, but remains a buy due to low valuation and potential EPS growth. Despite a sharp underperformance since early 2024 and a disappointing Q2, AEHR is diversifying revenue streams and expanding into AI processors, which could drive future growth. Key risks include ongoing supply chain issues, competition, and uncertainties in the silicon carbide market, but recent positive economic data from China offers hope for a turnaround. Technically, AEHR faces resistance at $10 and bearish indicators, but a bullish response to earnings could target a long-term upside gap around $16. Read the full article on Seeking Alpha
Valuation Update With 7 Day Price Move • Mar 17Investor sentiment improves as stock rises 20%After last week's 20% share price gain to US$9.77, the stock trades at a trailing P/E ratio of 13.2x. Average forward P/E is 21x in the Semiconductor industry in the US. Total loss to shareholders of 4.4% over the past three years.
Valuation Update With 7 Day Price Move • Feb 19Investor sentiment improves as stock rises 22%After last week's 22% share price gain to US$12.47, the stock trades at a trailing P/E ratio of 16.8x. Average forward P/E is 24x in the Semiconductor industry in the US. Total returns to shareholders of 6.3% over the past three years.
분석 기사 • Feb 06Not Many Are Piling Into Aehr Test Systems, Inc. (NASDAQ:AEHR) Stock Yet As It Plummets 34%Aehr Test Systems, Inc. ( NASDAQ:AEHR ) shareholders won't be pleased to see that the share price has had a very rough...
Valuation Update With 7 Day Price Move • Jan 20Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to US$12.46, the stock trades at a trailing P/E ratio of 16.8x. Average forward P/E is 21x in the Semiconductor industry in the US. Total returns to shareholders of 5.3% over the past three years.
Price Target Changed • Jan 17Price target decreased by 24% to US$19.00Down from US$25.00, the current price target is provided by 1 analyst. New target price is 52% above last closing price of US$12.46. Stock is down 25% over the past year. The company posted earnings per share of US$1.15 last year.
Seeking Alpha • Jan 16Aehr Test Systems: Selloff Was Justified But I'm Still Cautiously Optimistic (Rating Downgrade)Summary Aehr Test Systems' competitive advantage lies in its best-in-class test systems used for both EV and AI chips. The company's poor 2024 performance was due to an EV slowdown and reduced capex from its largest customer. Recent orders from AI and GaN customers signal strong growth for the second half of 2025 and increasing trust in Aehr's technology. Read the full article on Seeking Alpha
Reported Earnings • Jan 14Second quarter 2025 earnings released: US$0.035 loss per share (vs US$0.21 profit in 2Q 2024)Second quarter 2025 results: US$0.035 loss per share (down from US$0.21 profit in 2Q 2024). Revenue: US$13.5m (down 37% from 2Q 2024). Net loss: US$1.03m (down 117% from profit in 2Q 2024). Revenue is forecast to grow 34% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Semiconductor industry in the US. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
공지 • Jan 14Aehr Test Systems Reiterates Earnings Guidance for Fiscal Year Ending May 30, 2025For the fiscal year ending May 30, 2025, Aehr Test Systems, Inc. reiterated its previously provided guidance for total revenue of at least $70 million.
공지 • Jan 01Aehr Test Systems, Inc. to Report Q2, 2025 Results on Jan 13, 2025Aehr Test Systems, Inc. announced that they will report Q2, 2025 results at 4:00 PM, US Eastern Standard Time on Jan 13, 2025
Valuation Update With 7 Day Price Move • Dec 30Investor sentiment improves as stock rises 21%After last week's 21% share price gain to US$16.98, the stock trades at a trailing P/E ratio of 17.3x. Average forward P/E is 20x in the Semiconductor industry in the US. Total loss to shareholders of 27% over the past three years.
Seeking Alpha • Dec 17Aehr Test Systems: With A Turnaround In Sight, It's High On My Watchlist To Build A Proper PositionSummary Aehr Test Systems' share price dropped 30% since the last update but shows potential recovery, driven by positive news on diversification and SiC segment outlook. Latest earnings beat expectations with $13M in revenue, mainly from SiC; diversification into GaN and AI segments is progressing. Secured initial AI orders, boosting stock by 21%; diversification could bring significant revenue growth, but competition may arise. Despite positive signs, I remain cautious due to SiC market recovery uncertainty and macroeconomic factors, holding off on a buy rating for now. Read the full article on Seeking Alpha
분석 기사 • Dec 17Improved Earnings Required Before Aehr Test Systems, Inc. (NASDAQ:AEHR) Stock's 34% Jump Looks JustifiedAehr Test Systems, Inc. ( NASDAQ:AEHR ) shares have had a really impressive month, gaining 34% after a shaky period...
Valuation Update With 7 Day Price Move • Dec 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to US$14.49, the stock trades at a trailing P/E ratio of 14.7x. Average forward P/E is 20x in the Semiconductor industry in the US. Total loss to shareholders of 5.8% over the past three years.
공지 • Dec 06Gewirtz & Grossman LLC Notifies Class Action Lawsuit Filed Against Aehr Test Systems, IncGewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Aehr Test Systems, Inc. and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Aehr securities between January 9, 2024 and March 24, 2024, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site. The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) contrary to prior representations to investors, Aehr was continuing to experience substantial delays in customer orders; (2) the foregoing issue was likely to have a material negative impact on the Company's revenue growth; (3) accordingly, the Company's business and/or financial prospects were overstated; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/AEHR. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. If you suffered a loss in Aehr you have until February 3, 2025, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful. Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.
Valuation Update With 7 Day Price Move • Nov 01Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to US$14.08, the stock trades at a trailing P/E ratio of 14.3x. Average forward P/E is 21x in the Semiconductor industry in the US. Total loss to shareholders of 45% over the past three years.
분석 기사 • Oct 23Aehr Test Systems' (NASDAQ:AEHR) Earnings Might Not Be As Promising As They SeemAehr Test Systems, Inc.'s ( NASDAQ:AEHR ) stock performed strongly after the recent earnings report. Investors should...
분석 기사 • Oct 19Aehr Test Systems, Inc.'s (NASDAQ:AEHR) Shares Bounce 30% But Its Business Still Trails The MarketAehr Test Systems, Inc. ( NASDAQ:AEHR ) shareholders are no doubt pleased to see that the share price has bounced 30...
공지 • Oct 16Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $40 million.Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $40 million. Security Name: Common Stock Security Type: Common Stock Transaction Features: At the Market Offering
Reported Earnings • Oct 11First quarter 2025 earnings released: EPS: US$0.023 (vs US$0.16 in 1Q 2024)First quarter 2025 results: EPS: US$0.023 (down from US$0.16 in 1Q 2024). Revenue: US$13.1m (down 36% from 1Q 2024). Net income: US$660.0k (down 86% from 1Q 2024). Profit margin: 5.0% (down from 23% in 1Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Semiconductor industry in the US. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
공지 • Oct 11Aehr Test Systems, Inc. Reaffirms Earnings Guidance for the Fiscal Year Ending May 30, 2025Aehr Test Systems, Inc. reaffirms earnings guidance for the fiscal year ending May 30, 2025. For the fiscal year ending May 30, 2025, Aehr is reiterating its previously provided guidance for total revenue of at least $70 million and net profit before taxes of at least 10% of revenue.
Seeking Alpha • Oct 11Aehr Test Systems: Enthusiastic Management But Weak Near-Term Prospects, HoldSummary Shares of wafer level test and burn-in system supplier Aehr Test Systems rallied after the close of Thursday's regular session as investors cheered better-than-expected Q1/FY2025 results. Results and backlog benefited from the recent acquisition of Incal Technologies. As usual, management remained enthusiastic about the company's diversification into new markets, including AI. However, expansion into new markets won't offset persistent weakness in the core silicon carbide system business anytime soon. While market participants are likely to celebrate perceived AI market prospects in the near-term, persistent weakness in the company's core business is keeping me sidelined for now. Read the full article on Seeking Alpha
공지 • Oct 02Aehr Test Systems, Inc. to Report Q1, 2025 Results on Oct 10, 2024Aehr Test Systems, Inc. announced that they will report Q1, 2025 results After-Market on Oct 10, 2024
공지 • Sep 12Aehr Test Systems, Inc., Annual General Meeting, Oct 21, 2024Aehr Test Systems, Inc., Annual General Meeting, Oct 21, 2024. Location: 400 kato terrace, california 94539, fremont United States
분석 기사 • Sep 07Aehr Test Systems (NASDAQ:AEHR) Is Experiencing Growth In Returns On CapitalTo find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...
Valuation Update With 7 Day Price Move • Aug 06Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to US$15.01, the stock trades at a trailing P/E ratio of 13.4x. Average forward P/E is 18x in the Semiconductor industry in the US. Total returns to shareholders of 131% over the past three years.
Recent Insider Transactions • Aug 01Independent Director recently sold US$186k worth of stockOn the 30th of July, Fariba Danesh sold around 10k shares on-market at roughly US$18.59 per share. This transaction amounted to 70% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$967k more than they bought in the last 12 months.
Price Target Changed • Jul 18Price target increased by 108% to US$25.00Up from US$12.00, the current price target is provided by 1 analyst. New target price is 33% above last closing price of US$18.83. Stock is down 61% over the past year. The company posted earnings per share of US$1.15 last year.
Reported Earnings • Jul 17Full year 2024 earnings released: EPS: US$1.15 (vs US$0.52 in FY 2023)Full year 2024 results: EPS: US$1.15 (up from US$0.52 in FY 2023). Revenue: US$66.2m (up 1.9% from FY 2023). Net income: US$33.2m (up 128% from FY 2023). Profit margin: 50% (up from 22% in FY 2023). The increase in margin was primarily driven by lower expenses. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Semiconductor industry in the US. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.
공지 • Jul 17Aehr Test Systems (NasdaqCM:AEHR) agreed to acquire Incal Technology, Inc for $23.1.Aehr Test Systems (NasdaqCM:AEHR) agreed to acquire Incal Technology, Inc for $23.1 on July 15, 2024. A cash consideration of $14 million will be paid by Aehr Test Systems. The consideration consists of 0.55 million common equity of Aehr Test Systems to be issued for common equity of Incal Technology, Inc. The transaction has been approved by the board of directors of both companies and the Acquisition is expected to close within 60 days, subject to customary closing conditions. The transaction is subject to certain post-closing adjustments with respect to working capital. Latham & Watkins LLP acted as legal advisor for Aehr Test Systems.
분석 기사 • Jul 17Aehr Test Systems' (NASDAQ:AEHR) 27% Share Price Surge Not Quite Adding UpDespite an already strong run, Aehr Test Systems ( NASDAQ:AEHR ) shares have been powering on, with a gain of 27% in...
공지 • Jul 17Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 30, 2025Aehr Test Systems provided earnings guidance for the fiscal year ending May 30, 2025. For the period, the company expects total revenue of at least $70 million and net profit before taxes of at least 10% of revenue.
Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improves as stock rises 40%After last week's 40% share price gain to US$15.75, the stock trades at a trailing P/E ratio of 29.6x. Average forward P/E is 23x in the Semiconductor industry in the US. Total returns to shareholders of 363% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$9.07 per share.
공지 • Jul 04Aehr Test Systems to Report Q4, 2024 Results on Jul 16, 2024Aehr Test Systems announced that they will report Q4, 2024 results After-Market on Jul 16, 2024
Buy Or Sell Opportunity • Jul 01Now 23% overvaluedOver the last 90 days, the stock has fallen 6.6% to US$11.10. The fair value is estimated to be US$8.99, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year.
Valuation Update With 7 Day Price Move • Jun 27Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to US$10.17, the stock trades at a trailing P/E ratio of 19.1x. Average forward P/E is 23x in the Semiconductor industry in the US. Total returns to shareholders of 268% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$8.97 per share.
Buy Or Sell Opportunity • Jun 22Now 20% overvaluedOver the last 90 days, the stock has fallen 26% to US$10.80. The fair value is estimated to be US$8.97, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year.
New Risk • Jun 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings are forecast to decline by an average of 14% per year for the foreseeable future. High level of non-cash earnings (34% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Shareholders have been diluted in the past year (2.0% increase in shares outstanding).
Seeking Alpha • Jun 07Aehr Test Systems: The Bottom Might Be InSummary Aehr Test Systems may be at the bottom of its business cycle, and long-term growth potential remains. The company's financials have been impacted by slower demand and falling revenues, but stronger bookings and backlog are encouraging signs of a reversal of the slowdown. The market growth potential for AEHR is strong, the EV market should drive growth for years to come. Read the full article on Seeking Alpha
분석 기사 • Jun 06We Like These Underlying Return On Capital Trends At Aehr Test Systems (NASDAQ:AEHR)Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...
Valuation Update With 7 Day Price Move • Jun 05Investor sentiment improves as stock rises 15%After last week's 15% share price gain to US$12.75, the stock trades at a trailing P/E ratio of 23.9x. Average forward P/E is 21x in the Semiconductor industry in the US. Total returns to shareholders of 381% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$8.78 per share.
Board Change • Jun 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Independent Director Fariba Danesh was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
분석 기사 • May 01Why Aehr Test Systems (NASDAQ:AEHR) Could Be Worth WatchingAehr Test Systems ( NASDAQ:AEHR ), is not the largest company out there, but it saw a double-digit share price rise of...
Buy Or Sell Opportunity • Apr 24Now 24% overvaluedOver the last 90 days, the stock has fallen 32% to US$11.14. The fair value is estimated to be US$8.96, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year.
분석 기사 • Apr 18Aehr Test Systems' (NASDAQ:AEHR) Solid Earnings May Rest On Weak FoundationsAehr Test Systems' ( NASDAQ:AEHR ) robust recent earnings didn't do much to move the stock. However the statutory...
New Risk • Apr 12New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 14% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings are forecast to decline by an average of 14% per year for the foreseeable future. High level of non-cash earnings (34% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Shareholders have been diluted in the past year (4.2% increase in shares outstanding). Significant insider selling over the past 3 months (US$152k sold).
Reported Earnings • Apr 10Third quarter 2024 earnings released: US$0.051 loss per share (vs US$0.15 profit in 3Q 2023)Third quarter 2024 results: US$0.051 loss per share (down from US$0.15 profit in 3Q 2023). Revenue: US$7.56m (down 56% from 3Q 2023). Net loss: US$1.47m (down 136% from profit in 3Q 2023). Revenue is expected to decline by 5.7% p.a. on average during the next 2 years, while revenues in the Semiconductor industry in the US are expected to grow by 16%. Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 72% per year, which means it is significantly lagging earnings growth.
공지 • Apr 10Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024Aehr Test Systems provides earnings guidance for the fiscal year ending May 31, 2024. For the period, the company reiterating its previously provided guidance for total revenue of greater than $65 million and GAAP net income of approximately $11 million or more, or $0.38 per diluted share.
분석 기사 • Apr 01Some Confidence Is Lacking In Aehr Test Systems (NASDAQ:AEHR) As Shares Slide 30%Unfortunately for some shareholders, the Aehr Test Systems ( NASDAQ:AEHR ) share price has dived 30% in the last thirty...
Valuation Update With 7 Day Price Move • Mar 29Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to US$12.40, the stock trades at a trailing P/E ratio of 17x. Average forward P/E is 21x in the Semiconductor industry in the US. Total returns to shareholders of 382% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$7.15 per share.
공지 • Mar 26Aehr Test Systems to Report Q3, 2024 Results on Apr 09, 2024Aehr Test Systems announced that they will report Q3, 2024 results on Apr 09, 2024
Valuation Update With 7 Day Price Move • Mar 15Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to US$14.50, the stock trades at a trailing P/E ratio of 19.9x. Average forward P/E is 21x in the Semiconductor industry in the US. Total returns to shareholders of 464% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$7.14 per share.
분석 기사 • Feb 21Investors Shouldn't Overlook Aehr Test Systems' (NASDAQ:AEHR) Impressive Returns On CapitalThere are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...
Seeking Alpha • Feb 14Aehr Test Systems Faces Cyclical Headwinds (Rating Downgrade)Summary Aehr Test Systems has experienced cyclical headwinds that have affected its near-term prospects. Despite these challenges, the company's proprietary wafer-level test systems continue to benefit from rising demand for chips that require thorough testing. AEHR's XP systems, which can test multiple wafers at once, offer cost and space savings, and the company has additional growth opportunities in segments such as SiC, GaN, and SiPh. The cyclical headwinds will pass but could very well last a little longer. Read the full article on Seeking Alpha
Valuation Update With 7 Day Price Move • Feb 12Investor sentiment improves as stock rises 17%After last week's 17% share price gain to US$17.21, the stock trades at a trailing P/E ratio of 23.6x. Average forward P/E is 19x in the Semiconductor industry in the US. Total returns to shareholders of 450% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$7.30 per share.
Recent Insider Transactions Derivative • Feb 10Founder & Independent Chairman exercised options to buy US$310k worth of stock.On the 6th of February, Rhea Posedel exercised options to buy 18k shares at a strike price of around US$3.93, costing a total of US$71k. This transaction amounted to 3.8% of their direct individual holding at the time of the trade. Since June 2023, Rhea's direct individual holding has decreased from 571.22k shares to 477.11k. Company insiders have collectively sold US$21m more than they bought, via options and on-market transactions in the last 12 months.
분석 기사 • Feb 01Should You Investigate Aehr Test Systems (NASDAQ:AEHR) At US$14.85?Aehr Test Systems ( NASDAQ:AEHR ), is not the largest company out there, but it received a lot of attention from a...
New Risk • Jan 22New minor risk - Insider sellingThere has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: US$160k This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (52% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Shareholders have been diluted in the past year (3.9% increase in shares outstanding). Significant insider selling over the past 3 months (US$160k sold).
